Growth Potential Is Massive: Mylan N.V. (MYL)

Mylan N.V.’s stock (NASDAQ:MYL) has been rated as Outperform by Wolfe Research. This latest rating was contained in a recent research note published by...

Arconic Inc. (ARNC) Still A Mixed Bag, But Technicals Should Support Share Price

Arconic Inc.’s stock (NYSE:ARNC) has been rated as Outperform by Cowen. This latest rating was contained in a recent research note published by the...

The Upgrades Are Coming? Sabre Corporation (SABR)

Sabre Corporation’s stock (NASDAQ:SABR) has been rated as Buy by BofA/Merrill. This latest rating was contained in a recent research note published by the...

Vonage Holdings Corp. (VG) Represents A Potential Buying Opportunity?

Vonage Holdings Corp.’s stock (NYSE:VG) has been rated as Equal-Weight by Morgan Stanley. This latest rating was contained in a recent research note published...

Is Teradyne Inc. (TER) Can Survive is Current Scenario?

Teradyne Inc.’s stock (NASDAQ:TER) has been rated as Hold by Stifel. This latest rating was contained in a recent research note published by the...

Should Create Upside? CNX Resources Corporation (CNX)

CNX Resources Corporation’s stock (NYSE:CNX) has been rated as Sector Weight by KeyBanc Capital Markets. This latest rating was contained in a recent research...

Using Historical Data To Identify Symantec Corporation (SYMC)

Symantec Corporation’s stock (NASDAQ:SYMC) has been rated as Neutral by Monness Crespi & Hardt. This latest rating was contained in a recent research note...

Northrop Grumman Corporation (NOC) Needs Fundamental Boost Before A Recovery Can Happen

Northrop Grumman Corporation’s stock (NYSE:NOC) has been rated as Overweight by Morgan Stanley. This latest rating was contained in a recent research note published...

Time To Tread Carefully: NVIDIA Corporation (NVDA)

NVIDIA Corporation’s stock (NASDAQ:NVDA) has been rated as Buy by BofA/Merrill. This latest rating was contained in a recent research note published by the...

Future Is Still Highly Uncertain: Arrowhead Pharmaceuticals Inc. (ARWR)

Arrowhead Pharmaceuticals Inc.’s stock (NASDAQ:ARWR) has been rated as Outperform by Robert W. Baird. This latest rating was contained in a recent research note...